UBS-J.P.M.DL EM ADLA
UBS-J.P.M.DL EM ADLA
ETF · LU1974695790 · A2PGQ8 (XFRA)
Overview
No Price
19.09.2025 11:12
1 day
-
1 week
-
1 month
-
3 months
-
6 months
-
Year to date
-
1 year
-
2 years
-
3 years
-
4 years
-
5 years
-
10 years
-
20 years
-
Max
-
Current Prices from UBS-J.P.M.DL EM ADLA
ExchangeTickerCurrencyLast TradePriceDaily Change
XETR: XETRA
XETRA
EMIG.DE
EUR
19.09.2025 11:12
11,92 EUR
-0,004 EUR
-0,03 %
XLON: London
London
EMIG.L
GBX
18.09.2025 16:15
1.035,40 GBX
6,50 GBX
+0,63 %
Company Profile for UBS-J.P.M.DL EM ADLA ETF
The sub-fund aims to track, before expenses, the price and income performance of the J.P. Morgan USD EM IG ESG Diversified Bond Index (Total Return) (this sub-fund's "Index"). Additionally currency hedged share classes aim to reduce the impact of currency fluctuations between their reference currency and the index currency by selling currency forwards at the one-month forward rate in accordance with the hedging methodology of the Index's currency-hedged index variant as referred to in relation to each hedged share class below.

Company Data

Name UBS-J.P.M.DL EM ADLA
Company UBS(Lux)Fund Solutions – J.P. Morgan USD EM IG ESG Diversified Bond UCITS ETF(USD)A-acc
Primary Exchange XFRA Frankfurt
WKN A2PGQ8
ISIN LU1974695790
Asset Class ETF
Sector Financial Services
Industry Asset Management
Market Capitalization 569 Mio
Country United States of America
Currency EUR
Employees -
IPO Date 2019-08-02

Ticker Symbols

Name Symbol
Frankfurt EMIG.F
London EMIG.L
XETRA EMIG.DE
More Shares
Investors who hold UBS-J.P.M.DL EM ADLA also have the following shares in their portfolio:
REC LIMITED 3.50% NTS 12/12/24 (REG S)
REC LIMITED 3.50% NTS 12/12/24 (REG S) Bond
Verve Therapeutics, Inc. - Common Stock
Verve Therapeutics, Inc. - Common Stock Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025